Bruijnincx, Pieter C. A. and Sadler, P. J. (2008) New trends for metal complexes with anticancer activity. Current Opinion in Chemical Biology, Vol.12 (No.2). pp. 197-206. doi:10.1016/j.cbpa.2007.11.013 ISSN 1367-5931.

PDF WRAP_Sadler_New_Trends_PMID_18155674_COCB_WRAP.pdf - Requires a PDF viewer. Download (754Kb)

Request Changes to record.

Abstract

Medicinal inorganic chemistry can exploit the unique properties of metal ions for the design of new drugs. This has, for instance, led to the clinical application of chemotherapeutic agents for cancer treatment, such as cisplatin. The use of cisplatin is, however, severely limited by its toxic side-effects. This has spurred chemists to employ different strategies in the development of new metal-based anticancer agents with different mechanisms of action. Recent trends in the field are discussed in this review. These include the more selective delivery and/or activation of cisplatin-related prodrugs and the discovery of new non-covalent interactions with the classical target, DNA. The use of the metal as scaffold rather than reactive centre and the departure from the cisplatin paradigm of activity towards a more targeted, cancer cell-specific approach, a major trend, are discussed as well. All this, together with the observation that some of the new drugs are organometallic complexes, illustrates that exciting times lie ahead for those interested in ‘metals in medicine.

Item Type:	Journal Article
Subjects:	R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions:	Faculty of Science, Engineering and Medicine > Science > Chemistry
Library of Congress Subject Headings (LCSH):	Cisplatin -- Research, Metals in medicine, Organometallic compounds, Cancer -- Treatment, Metal ions -- Research
Journal or Publication Title:	Current Opinion in Chemical Biology
Publisher:	Elsevier Ltd.
ISSN:	1367-5931
Official Date:	April 2008
Dates:	Date Event April 2008 Published
Volume:	Vol.12
Number:	No.2
Number of Pages:	10
Page Range:	pp. 197-206
DOI:	10.1016/j.cbpa.2007.11.013
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Open Access (Creative Commons)
Funder:	Royal Society (Great Britain), Engineering and Physical Sciences Research Council (EPSRC), Biotechnology and Biological Sciences Research Council (Great Britain) (BBSRC), Nederlandse Organisatie voor Wetenschappelijk Onderzoek [Netherlands Organisation for Scientific Research] (NWO), Wellcome Trust (London, England), European Cooperation in the Field of Scientific and Technical Research (Organization) (COST), Scottish Enterprise (SE), Oncosense Ltd.

Data sourced from Thomson Reuters' Web of Knowledge

Request changes or add full text files to a record

Repository staff actions (login required)

View Item

Downloads